Sign In
Buy GMDA
$0.0327
+0 (+0%)
At Close: Aug 27, 2024
Why Gamida Cell Stock Is Soaring Today
02:44pm, Wednesday, 10'th Feb 2021
The company released data from a late-stage clinical trial.
GMDA Stock Price Increases Over 40% Pre-Market: Why It Happened
06:59am, Wednesday, 10'th Feb 2021
The stock price of Gamida Cell Ltd (NASDAQ: GMDA) is trading over 40% pre-market as of 6:52 AM ET. This is why it happened.
BOSTON--(BUSINESS WIRE)--Gamida Cell Ltd. (Nasdaq: GMDA), an advanced cell therapy company committed to cures for blood cancers and serious hematologic diseases, today announced the results of a Phase
BOSTON--(BUSINESS WIRE)--Gamida Cell Ltd. (Nasdaq: GMDA), an advanced cell therapy company committed to cures for blood cancers and serious hematologic diseases, today announced that the full results
BOSTON--(BUSINESS WIRE)--Gamida Cell Ltd. (Nasdaq: GMDA), an advanced cell therapy company committed to cures for blood cancers and serious hematologic diseases, today announced that its previously an
Gamida Cell Announces Launch of Public Offering of Ordinary Shares
09:03pm, Wednesday, 16'th Dec 2020
BOSTON--(BUSINESS WIRE)--Gamida Cell Ltd. (Nasdaq: GMDA), an advanced cell therapy company committed to cures for blood cancers and serious hematologic diseases, today announced the launch of a follow
Gamida Cell Provides Regulatory Update on Biologics License Application for Omidubicel
07:00am, Monday, 14'th Dec 2020
BOSTON--(BUSINESS WIRE)--Gamida Cell Ltd. (Nasdaq: GMDA), an advanced cell therapy company committed to cures for blood cancers and serious hematologic diseases, today announced that the company condu
Why Is Everyone Talking About Gamida Cell Stock?
08:21am, Thursday, 10'th Dec 2020
Early data for this company's natural killer cells is drawing lots of attention.
Why Gamida, Scpharmaceuticals And Hookipa Are Moving Today
12:24pm, Monday, 07'th Dec 2020
Gamida Cell (NASDAQ: GMDA) shares are trading higher on Monday following the company's Saturday GDA-201 presentation at the American Society of Hematology Annual Meeting. Gamida Cell is a biopharmace
BOSTON--(BUSINESS WIRE)--Gamida Cell Ltd. (Nasdaq: GMDA), an advanced cell therapy company committed to cures for blood cancers and serious hematologic diseases, today announced in an oral presentatio
Gamida Cell to Host Virtual Pipeline Deep Dive
08:01am, Wednesday, 02'nd Dec 2020
BOSTON--(BUSINESS WIRE)--Gamida Cell Ltd. (Nasdaq: GMDA), an advanced cell therapy company committed to cures for blood cancers and serious blood diseases, announced today that it will host a virtual
Gamida Cell Ltd (GMDA) CEO Julian Adams on Q3 2020 Results - Earnings Call Transcript
03:50am, Wednesday, 11'th Nov 2020
Gamida Cell Ltd (GMDA) CEO Julian Adams on Q3 2020 Results - Earnings Call Transcript
Gamida Cell Reports Third Quarter 2020 Financial Results and Provides Company Update
08:01am, Tuesday, 10'th Nov 2020
BOSTON--(BUSINESS WIRE)--Gamida Cell Ltd. (Nasdaq: GMDA), an advanced cell therapy company committed to finding cures for blood cancers and serious blood diseases, today reported financial results for
Gamida Cell Announces Data to Be Presented at 62nd ASH Annual Virtual Meeting
10:30am, Wednesday, 04'th Nov 2020
BOSTON--(BUSINESS WIRE)--Gamida Cell Ltd. (Nasdaq: GMDA), a leading cellular and immune therapeutics company, today announced that updated data from the ongoing Phase 1 clinical study of GDA-201, an i
Gamida Cell to Present at H.C. Wainwright 6th Annual Israel Conference
08:01am, Wednesday, 04'th Nov 2020
BOSTON--(BUSINESS WIRE)--Gamida Cell Ltd. (Nasdaq: GMDA), an advanced cell therapy company committed to cures for blood cancers and serious blood diseases, today announced that Julian Adams, Ph. D., c
